SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-23-014000
Filing Date
2023-04-28
Accepted
2023-04-28 12:39:46
Documents
19

Document Format Files

Seq Description Document Type Size
1 DEF 14A aadi-20230428.htm   iXBRL DEF 14A 607279
6 aadi-20230428_g1.jpg GRAPHIC 2935
7 aadi-20230428_g2.jpg GRAPHIC 328703
8 aadi-20230428_g3.jpg GRAPHIC 305812
9 aadi-20230428_g4.jpg GRAPHIC 242880
10 aadi-20230428_g5.jpg GRAPHIC 242249
  Complete submission text file 0001628280-23-014000.txt   3938846

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20230428.xsd EX-101.SCH 4670
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aadi-20230428_def.xml EX-101.DEF 6926
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20230428_lab.xml EX-101.LAB 10033
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20230428_pre.xml EX-101.PRE 6206
13 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20230428_htm.xml XML 134955
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38560 | Film No.: 23863003
SIC: 2834 Pharmaceutical Preparations